The announcement from PROCEPT BioRobotics is eagerly anticipated, with investors seeking news of surpassing estimates and ...

Q2 2025 Management View CEO Reza Zadno highlighted the company’s leadership transition, stating that PROCEPT is entering this change “from a position of strength, supported by several sustainable ...

NasdaqGM:PRCT 1 Year Share Price vs Fair Value Explore PROCEPT BioRobotics's Fair Values from the Community and ...

Q2 2025 Earnings Call Transcript August 7, 2025 Operator: Good afternoon, and welcome to the PROCEPT BioRobotics Second Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, ...

Understand the cash flow statement for PROCEPT BioRobotics Corporation (PRCT), learn where the money comes from and how the company spends it.

These 10 stocks could mint the next wave of millionaires › Procept BioRobotics (NASDAQ:PRCT), a medical technology company specializing in robotic surgical systems for benign prostatic hyperplasia ...

Analysts have set 12-month price targets for PROCEPT BioRobotics, revealing an average target of $79.0, a high estimate of $94.00, and a low estimate of $69.00.

Longtime leader of Edwards' largest business unit Larry Wood is joining Procept BioRobotics as CEO and president, effective Sept. 1.

Procept BioRobotics' surgical bots tackle a perplexing prostate problem, boosting the San Jose company's financial results.

Shares of Procept BioRobotics fell after the company said Chief Executive Reza Zadno would resign and be replaced by Edwards Lifesciences executive Larry Wood. The stock was down 8% to $53.96 on ...

PITTSBURGH (KDKA) -- A team from Carnegie Mellon University's Biorobotics Lab created a robot that can swim. The snake-like robot was developed to inspect Navy ships. CMU says the robot's narrow ...